Validation of the Polish version of the EORTC QLQ-CX24 module for the assessment of health-related quality of life in women with cervical cancer

2013 ◽  
Vol 23 (2) ◽  
pp. 214-220 ◽  
Author(s):  
D. Paradowska ◽  
K.A. Tomaszewski ◽  
M. Bałajewicz-Nowak ◽  
K. Bereza ◽  
I.M. Tomaszewska ◽  
...  
2013 ◽  
Vol 14 (1) ◽  
pp. 157-163 ◽  
Author(s):  
Jan Paradowski ◽  
Krzysztof A Tomaszewski ◽  
Krzysztof Bereza ◽  
Iwona M Tomaszewska ◽  
Artur Pasternak ◽  
...  

2021 ◽  
Author(s):  
Mehreen Shajahan Ahamed ◽  
Amsalu Degu

Abstract Background: A previous systematic review showed that health-related quality of life (HRQoL) was adversely affected during treatment of cervical cancer, with a worsening global score. However, there was a lack of data in the study setting. Therefore, this study aimed to determine the HRQoL of cervical cancer patients at Kenyatta National Hospital.Methods: A cross-sectional design of the study was employed among cervical cancer patients. All eligible cervical cancer patients during the study period were included in the study. Hence, a consecutive sample of 103 cervical cancer patients was involved in the study. Following consent, study participants were interviewed using The European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire 30 (EORTC QLQ-30) and Cervical Cancer Module CX24 (EORTC QLQ-CX24). The clinical characteristics and treatment regimens were collected by reviewing the medical records. Interpretation and linear transformation of the raw score of health-related quality of life were conducted as per EORTC QLQ 30 and EORTC QLQ-CX24 Scoring Manual. The data were entered and analyzed using the Statistical Package for Social Sciences version 20.0 software. Frequency tables mean, percentage, and figures were used to represent the data. Univariate and multivariate binary logistic regression analysis was employed to investigate the associated factors of health-related quality of life. A p-value of ≤ 0.05 was considered statistically significant. Results: The mean age of the participant population was found to be 55.8 ± 5.6 years. Most of the study participants had stage III cervical cancer (56.3%) and without comorbidities (65%). The mean score of the global health status was 41.99. The physical functioning, cognitive functioning, and financial difficulties mean scores were 71.6, 73.3, and 93.5, respectively. Under the symptom scale, nausea and vomiting, pain, and appetite loss had mean scores of 70.1, 67.2, and 66.0, respectively. The overall quality of life data showed 69% of study participants had poor quality of life while 31% of study participants had good quality of life. Patients with early-stage disease (stage I and II) were 7.3 times (AOR = 7.3, 95% CI = 2.4 – 21.7, p = 0.000) more likely to have a good quality of life than patients with advanced-stage disease. Patients with no comorbidities were 3.1 times (COR = 3.1, 95% CI = 1.1 – 9.1, p = 0.037) more likely to have a good quality of life than patients with comorbidities.Conclusions: The overall health-related quality of life among cervical cancer patients was poor in the study setting. Advanced stage of disease and presence of comorbidities were the significant predictors of poor quality of life.


2013 ◽  
Vol 23 (2) ◽  
pp. 527-532 ◽  
Author(s):  
Mirosława Püsküllüoğlu ◽  
Krzysztof A. Tomaszewski ◽  
Andrew Bottomley ◽  
Lori Holden ◽  
Iwona M. Tomaszewska ◽  
...  

2013 ◽  
Vol 31 (2) ◽  
pp. 191-203 ◽  
Author(s):  
Krzysztof Andrzej Tomaszewski ◽  
Mirosława Püsküllüoğlu ◽  
Katarzyna Biesiada ◽  
Justyna Bochenek ◽  
Jaroslaw Nieckula ◽  
...  

Author(s):  
Vera Arsenyeva ◽  
Boris Martynov ◽  
Gennadiy Bulyshchenko ◽  
Dmitriy Svistov ◽  
Boris Gaydar ◽  
...  

Gliomas make up about 8 cases per 100,000 population and the number of patients with this disease is only increasing. There can be not only various types of neurological deficits among the symptoms, but also personal and emotional changes, that seriously affects the quality of life. The modern model of health care includes not only recovery of the patient’s physical functions, but also his or her psychosocial well-being. In particular, the assessment and study of the characteristics of health-related quality of life, as well as cognitive functions in patients with gliomas, is increasingly recognized as an important criterion when considering the effectiveness of treatment. To date, the features of health related quality of life and cognitive functions of patients with epilepsy and acute cerebral circulation disorders have been studied sufficiently, and, as a result, techniques have been developed that accurately assess the QOL and CF in patients with these diseases. These are QOLIE-31 and QOLIE-AD-48 questionnaires for patients with epilepsy. This is the National Institutes of Health Stroke Scale (NIHSS), Orgogozo stroke scale (OSS), World Federation of Neurological Surgeons (WFNS) scale for the clinical assessment of subarachnoid hemorrhage (SAH) for patients with acute cerebrovascular accident. At the same time, there are no generally accepted methods for assessing quality of life and neurocognitive functions that are sensitive to changes in the condition of patients with gliomas in the early postoperative period by the time of discharge from the hospital. As a result, there is no systematic information on the dynamics of the quality of life of such patients, their neurocognitive functioning. The purpose of this article was to study the literature on QOL and CF in patients affected by neurological and neurosurgical disorders for the further selection of optimal methods for assessing dynamics of the condition of patients with glial brain tumors before and after surgery. At the moment, such requirements are only partially met by the EORTC QLQ-C30 questionnaire and its application EORTC QLQ-BN20.


Author(s):  
Cynthia S. Bonhof ◽  
Lonneke V. van de Poll-Franse ◽  
Dareczka K. Wasowicz ◽  
Laurens V. Beerepoot ◽  
Gerard Vreugdenhil ◽  
...  

Abstract Purpose To gain more insight into the course of chemotherapy-induced peripheral neuropathy (CIPN) and its impact on health-related quality of life (HRQoL) in a population-based sample of colorectal cancer (CRC) patients up to 2 years after diagnosis. Methods All newly diagnosed CRC patients from four hospitals in the Netherlands were eligible for participation in an ongoing prospective cohort study. Patients (n = 340) completed questions on CIPN (EORTC QLQ-CIPN20) and HRQoL (EORTC QLQ-C30) before initial treatment (baseline) and 1 and 2 years after diagnosis. Results Among chemotherapy-treated patients (n = 105), a high sensory peripheral neuropathy (SPN) level was reported by 57% of patients at 1 year, and 47% at 2-year follow-up, whereas a high motor peripheral neuropathy (MPN) level was reported by 47% and 28%, at years 1 and 2, respectively. Linear mixed model analyses showed that SPN and MPN symptoms significantly increased from baseline to 1-year follow-up and did not return to baseline level after 2 years. Patients with a high SPN or MPN level reported a worse global quality of life and a worse physical, role, emotional, cognitive, and social functioning compared with those with a low SPN or MPN level. Conclusions Future studies should focus on understanding the mechanisms underlying CIPN so targeted interventions can be developed to reduce the impact of CIPN on patient’s lives. Implications for cancer survivors Patients need to be informed of both CIPN and the impact on HRQoL.


Author(s):  
Larissa dos Santos ◽  
Luciana Castaneda ◽  
Suzana de Aguiar ◽  
Luiz Thuler ◽  
Rosalina Koifman ◽  
...  

Objective To analyze the factors associated with health-related quality of life (HRQoL) in women with cervical cancer (CC) in a single center in Rio de Janeiro, state of Rio de Janeiro, Brazil. Methods A cross-sectional study in women with a diagnosis of CC followed-up in the gynecology outpatient clinic of the Hospital do Câncer II (HCII, in the Portuguese acronym) of the Instituto Nacional de Câncer (INCA, in the Portuguese acronym). The data were collected from March to August 2015. Women with palliative care, communication/cognition difficulty, undergoing simultaneous treatment for other types of cancer, or undergoing chemotherapy and/or radiation therapy were excluded. For the evaluation of the HRQoL, a specific questionnaire for women with CC was used (Functional Assessment of Cancer Therapy – Cervix Cancer [FACT-Cx]). The total score of the questionnaire ranges from 0 to 168, with higher scores indicating a better HRQoL. Results A total of 115 women were included in the present study, with a mean age of 52.64 years old (standard deviation [SD] = 12.13). The domains of emotional (16.61; SD = 4.55) and functional well-being (17.63; SD = 6.15) were those which presented the worst scores. The factors that had an association with better HRQoL in women with CC were having a current occupation, a longer time since the treatment and diagnosis, and women who had undergone hysterectomy. Conclusion Considering the domains of HRQoL of the women treated for cervical cancer, a better score was observed in the domains of physical and social/family well-being. For most domains, better scores were found between those with a current occupation, with a longer time after the diagnosis and treatment, and among those who had undergone a hysterectomy.


2009 ◽  
Vol 73 (5) ◽  
pp. 1501-1509 ◽  
Author(s):  
Ida J. Korfage ◽  
Marie-Louise Essink-Bot ◽  
Floortje Mols ◽  
Lonneke van de Poll-Franse ◽  
Roy Kruitwagen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document